Karen Fong, MD
Otolaryngology · Walnut Creek, CANPI 1548275068
Payments from drug & device makers
Across 92 payments — averaging $232.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$15K
- Sanofi$2K
- Aerin Medical Inc.$2K
- Inspire Medical Systems, Inc.$447
- Optinose US, Inc.$420
- Smith+Nephew$279
- plus $1K from 19 others
What the payments were for
- Consulting fees$17,22681%
- Travel & lodging$1,0895%
- Food & beverage$3,04214%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 5 | $15,175 |
| Sanofi | 5 | $2,318 |
| Aerin Medical Inc. | 14 | $1,601 |
| Inspire Medical Systems, Inc. | 11 | $447 |
| Optinose US, Inc. | 12 | $420 |
| Smith+Nephew | 10 | $279 |
| GSK | 6 | $241 |
| Regeneron Healthcare Solutions, Inc. | 3 | $148 |
| Pulmonx Corporation | 1 | $69 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $66 |
| Medtronic | 1 | $62 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $57 |
| Baxter Healthcare | 3 | $53 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| United Therapeutics Corporation | 2 | $51 |
| AstraZeneca | 2 | $45 |
| Merck | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Biocryst US Sales Co., LLC | 1 | $40 |
| Stryker | 1 | $33 |
| Amgen | 1 | $29 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| Philips North America LLC | 1 | $20 |
| Neurent Medical Limited | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$2,051
- VIVAER STYLUS$1,205
- Xhance$254
- Inspire$161
- RHINAER STYLUS$141
- NUCALA$122
How this compares
$21,356 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 75 | $2,761 |
| Azelastine Hcl | 50 | $2,290 |
| Prednisolone Acetate | 30 | $1,653 |
| Fluticasone Propionate | 38 | $453 |
| Montelukast Sodium | 19 | $279 |
| Mupirocin | 21 | $162 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $85 |
| Prednisone | 18 | $45 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Walnut Creek
- Jee-Hong KimWalnut Creek$131K
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.